GlaxoSmithKline's Rotarix gets regulatory green light

Article

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
© 2024 MJH Life Sciences

All rights reserved.